In another study aimed at uncovering the emergence of DTP populations following EGFR TKI treatment, Terai and colleagues [48] performed a genome-wide CRISPR-Cas9 screen in EGFR-dependent NSCLC cells treated with erlotinib and THZ1. Here, EGFR is linked to non-small cell lung carcinoma.